covid 19 News and Research

RSS

Study uncovers how novel coronavirus disrupts normal cell defenses to hijack human host cells

A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in the human body.

27 Oct 2021

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

27 Oct 2021

MU researchers receive $1.9 million grant to assess COVID-19 response in nursing homes

When Lori Popejoy and Amy Vogelsmeier were working as registered nurses early in their careers, they saw firsthand how quickly respiratory infections, such as the common flu, could spread in nursing homes.

27 Oct 2021

Fresh faces, fewer tools: Meet the new bosses fighting covid

Emilie Sayler's roots run deep in southwestern Montana. She serves on a nearby town council and the board of the local Little League. She went to college in a neighboring county and regularly volunteers in the schools of her three kids.

27 Oct 2021

Using deep brain stimulation to treat Parkinson’s Disease

News-Medical spoke to Dr. Aryn Gittis about her latest research into Parkinson's disease and how deep brain stimulation could be used to help treat it.

27 Oct 2021

Pharma campaign cash delivered to key lawmakers with surgical precision

The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking social spending bill.

27 Oct 2021

COVID-19 vaccine-elicited immune responses in myeloma patients

Researchers collaborated to address these evidence gaps by initiating a web-based prospective study of adults diagnosed with multiple myeloma to determine the immune response to the first and second dose of the COVID-19 vaccine.

27 Oct 2021

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Researchers conducted a study to assess how pre-existing mental disorders are associated with a SARS-CoV-2 infection and how different clusters of mental disorders affect COVID-19 clinical outcomes.

27 Oct 2021

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Researchers from the University of Veterinary Medicine Hannover have been investigating the spread of the disease in domestic cats in Europe.

27 Oct 2021

Model for the simulation of SARS-CoV-2 community transmission in congregate facilities

Researchers have examined the factors that caused the most significant outbreaks in congregate settings such as care homes and prisons.

27 Oct 2021

New study explains why Delta is so easily transmitted and infects people quickly

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published today in Science, explains why Delta is so easily spread and infects people so quickly, and suggests a more targeted strategy for developing future COVID-19 vaccines and treatments.

27 Oct 2021

How can we predict the number of future COVID-19 hospital admissions?

Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.

27 Oct 2021

Study shows sustained deterioration of mental health in UK across COVID pandemic

To date, it is not clear how the COVID-19 pandemic and implementation of various preventive strategies impacted mental health or which group of people were most affected by them. To address these issues, scientists have conducted coordinated analyses that included eleven UK longitudinal population studies, comprising data from before and throughout the pandemic.

27 Oct 2021

UK supports Viet Nam to combat COVID-19 by providing £500,000 of medical equipment

This commitment follows the donation by the UK government to Viet Nam of 415,050 doses of the University of Oxford-AstraZeneca vaccine in August 2021.

27 Oct 2021

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

Simple blood test useful for excluding pulmonary embolism among hospitalized COVID-19 patients

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University of South Florida Health (USF Health) Morsani College of Medicine research team reports.

26 Oct 2021

Guaranteed financial incentives for COVID-19 vaccination increase vaccine uptake

North Carolina's $25 Summer Card Pilot program successfully encouraged more adults to get a COVID-19 vaccine at a time when the pace of vaccination in North Carolina was slowing.

26 Oct 2021

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

covid 19 News and Research

Study uncovers how novel coronavirus disrupts normal cell defenses to hijack human host cells

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

MU researchers receive $1.9 million grant to assess COVID-19 response in nursing homes

Fresh faces, fewer tools: Meet the new bosses fighting covid

Using deep brain stimulation to treat Parkinson’s Disease

Pharma campaign cash delivered to key lawmakers with surgical precision

COVID-19 vaccine-elicited immune responses in myeloma patients

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Study of SARS-CoV-2 antibody seroprevalence among domestic cats

Model for the simulation of SARS-CoV-2 community transmission in congregate facilities

New study explains why Delta is so easily transmitted and infects people quickly

How can we predict the number of future COVID-19 hospital admissions?

Study shows sustained deterioration of mental health in UK across COVID pandemic

UK supports Viet Nam to combat COVID-19 by providing £500,000 of medical equipment

Postpartum women's experience of social restrictions during COVID-19

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

Simple blood test useful for excluding pulmonary embolism among hospitalized COVID-19 patients

Guaranteed financial incentives for COVID-19 vaccination increase vaccine uptake

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News